214 related articles for article (PubMed ID: 7784070)
1. Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.
Rasheed BK; McLendon RE; Friedman HS; Friedman AH; Fuchs HE; Bigner DD; Bigner SH
Oncogene; 1995 Jun; 10(11):2243-6. PubMed ID: 7784070
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.
Voesten AM; Bijleveld EH; Westerveld A; Hulsebos TJ
Genes Chromosomes Cancer; 1997 Oct; 20(2):167-72. PubMed ID: 9331567
[TBL] [Abstract][Full Text] [Related]
3. The putative glioma tumor suppressor gene on chromosome 19q maps between APOC2 and HRC.
Rubio MP; Correa KM; Ueki K; Mohrenweiser HW; Gusella JF; von Deimling A; Louis DN
Cancer Res; 1994 Sep; 54(17):4760-3. PubMed ID: 8062276
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity of chromosome 10p in human gliomas.
Kimmelman AC; Ross DA; Liang BC
Genomics; 1996 Jun; 34(2):250-4. PubMed ID: 8661060
[TBL] [Abstract][Full Text] [Related]
5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas.
Kon H; Sonoda Y; Kumabe T; Yoshimoto T; Sekiya T; Murakami Y
Oncogene; 1998 Jan; 16(2):257-63. PubMed ID: 9464544
[TBL] [Abstract][Full Text] [Related]
8. DMBT1 polymorphisms: relationship to malignant glioma tumorigenesis.
Sasaki H; Betensky RA; Cairncross JG; Louis DN
Cancer Res; 2002 Mar; 62(6):1790-6. PubMed ID: 11912156
[TBL] [Abstract][Full Text] [Related]
9. New deletion in low-grade oligodendroglioma at the glioblastoma suppressor locus on chromosome 10q25-26.
Maier D; Comparone D; Taylor E; Zhang Z; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1997 Aug; 15(8):997-1000. PubMed ID: 9285695
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
11. Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Hong WK; Mao L
Oncogene; 1998 Oct; 17(13):1749-53. PubMed ID: 9796705
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas.
Olopade OI; Jenkins RB; Ransom DT; Malik K; Pomykala H; Nobori T; Cowan JM; Rowley JD; Diaz MO
Cancer Res; 1992 May; 52(9):2523-9. PubMed ID: 1568221
[TBL] [Abstract][Full Text] [Related]
13. Two distinct regions involved in 1p deletion in human primary breast cancer.
Bièche I; Champème MH; Matifas F; Cropp CS; Callahan R; Lidereau R
Cancer Res; 1993 May; 53(9):1990-4. PubMed ID: 8097672
[TBL] [Abstract][Full Text] [Related]
14. A common region of homozygous deletion in malignant human gliomas lies between the IFN alpha/omega gene cluster and the D9S171 locus.
Ichimura K; Schmidt EE; Yamaguchi N; James CD; Collins VP
Cancer Res; 1994 Jun; 54(12):3127-30. PubMed ID: 8205529
[TBL] [Abstract][Full Text] [Related]
15. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
16. Loss of heterozygosity for 10q loci in human gliomas.
Rasheed BK; Fuller GN; Friedman AH; Bigner DD; Bigner SH
Genes Chromosomes Cancer; 1992 Jul; 5(1):75-82. PubMed ID: 1384665
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity at 11p15 in malignant glioma.
Sonoda Y; Iizuka M; Yasuda J; Makino R; Ono T; Kayama T; Yoshimoto T; Sekiya T
Cancer Res; 1995 May; 55(10):2166-8. PubMed ID: 7743518
[TBL] [Abstract][Full Text] [Related]
18. Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer.
Trybus TM; Burgess AC; Wojno KJ; Glover TW; Macoska JA
Cancer Res; 1996 May; 56(10):2263-7. PubMed ID: 8625295
[TBL] [Abstract][Full Text] [Related]
19. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas.
Balesaria S; Brock C; Bower M; Clark J; Nicholson SK; Lewis P; de Sanctis S; Evans H; Peterson D; Mendoza N; Glaser MG; Newlands ES; Fisher RA
Br J Cancer; 1999 Dec; 81(8):1371-7. PubMed ID: 10604735
[TBL] [Abstract][Full Text] [Related]
20. Deletion mapping of gliomas suggest the presence of two small regions for candidate tumor-suppressor genes in a 17-cM interval on chromosome 10q.
Albarosa R; Colombo BM; Roz L; Magnani I; Pollo B; Cirenei N; Giani C; Conti AM; DiDonato S; Finocchiaro G
Am J Hum Genet; 1996 Jun; 58(6):1260-7. PubMed ID: 8651304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
